Your browser doesn't support javascript.
loading
A multicenter phase II study of sorafenib in combination with erlotinib in patients with advanced non-small cell lung cancer (KCSG-0806).
Lim, Sun Min; Cho, Byoung Chul; Kim, Sang-We; Kang, Seok Yun; Heo, Dae Seog; Kim, Heung Tae; Lee, Dae Ho; Kim, Dong-Wan; Jung, Minkyu; Choi, Jin-Hyuk; Shim, Hyo Sup; Choi, Jong Rak; Kim, Joo-Hang.
Afiliación
  • Lim SM; Division of Medical Oncology, Department of Internal Medicine, CHA University Bundang Medical Center, Seongnam, South Korea; Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
  • Cho BC; Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
  • Kim SW; Department of Medical Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
  • Kang SY; Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, South Korea.
  • Heo DS; Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.
  • Kim HT; National Cancer Center, Goyang-si, South Korea.
  • Lee DH; Department of Medical Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
  • Kim DW; Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea.
  • Jung M; Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.
  • Choi JH; Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, South Korea.
  • Shim HS; Department of Pathology, Yonsei University College of Medicine, Seoul, South Korea.
  • Choi JR; Department of Laboratory Medicine, Yonsei University, College of Medicine, Seoul, South Korea.
  • Kim JH; Division of Medical Oncology, Department of Internal Medicine, CHA University Bundang Medical Center, Seongnam, South Korea; Division of Medical Oncology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea. Electronic address: kim123@cha.ac.kr.
Lung Cancer ; 93: 1-8, 2016 Mar.
Article en En | MEDLINE | ID: mdl-26898607
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: Corea del Sur Pais de publicación: Irlanda
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lung Cancer Asunto de la revista: NEOPLASIAS Año: 2016 Tipo del documento: Article País de afiliación: Corea del Sur Pais de publicación: Irlanda